Table 4 Effect of TAC with MMF or CYC on the complete response in SLE patients
TAC/CYC/MMF | Non-CR, n (%) | CR, n (%) | OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|---|---|
CYC as reference | ||||
 CYC | 258(75.7) | 83(24.3) | 1.00 | 1.00 |
 TAC | 51(58.6) | 36(41.4) | 1.72(1.04,2.85) | 1.97(1.10,3.53) |
 TAC + CYC | 43(65.2) | 23(34.8) | 2.02(1.16,3.51) | 2.15(1.15,4.02) |
 TAC + MMF | 26(53.1) | 23(46.9) | 2.75(1.49,5.08) | 2.43(1.20,4.92) |
 TAC + MMF + CYC | 21(50.0) | 21(50.0) | 3.11(1.62,5.98) | 2.69(1.33,5.45) |
  P TAC*CYC |  |  | 0.038 | 0.043 |
MMF as reference | ||||
 MMF | 101(77.7) | 29(22.3) | 1.00 | 1.00 |
 TAC | 51(58.6) | 36(41.4) | 2.46(1.36,4.45) | 2.89(1.50,5.58) |
 TAC + MMF | 26(53.1) | 23(46.9) | 3.08(1.54,6.18) | 3.54(1.66,7.58) |
 TAC + CYC | 43(65.2) | 23(34.8) | 1.86(0.97,3.58) | 3.14(1.49,6.64) |
 TAC + MMF + CYC | 21(50.0) | 21(50.0) | 3.48(1.67,7.24) | 3.94(1.74,8.95) |
  P TAC*MMF |  |  | 0.013 | 0.025 |